Version 5.4
Bos taurus Protein: TRIM63
Summary
InnateDB Protein IDBP-697928.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol TRIM63
Protein Name E3 ubiquitin-protein ligase TRIM63
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000037722
InnateDB Gene IDBG-645236 (TRIM63)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 82 interaction(s) predicted by orthology.
Predicted by orthology
Total 82 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004842 ubiquitin-protein transferase activity
GO:0005515 protein binding
GO:0008270 zinc ion binding
GO:0031432 titin binding
GO:0046872 metal ion binding
Biological Process
GO:0010468 regulation of gene expression
GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process
GO:0071549 cellular response to dexamethasone stimulus
Cellular Component
GO:0005622 intracellular
Protein Structure and Domains
PDB ID
InterPro IPR000315 Zinc finger, B-box
IPR001841 Zinc finger, RING-type
IPR003649 B-box, C-terminal
IPR018957 Zinc finger, C3HC4 RING-type
PFAM PF00643
PF13639
PF14634
PF00097
PRINTS
PIRSF
SMART SM00336
SM00184
SM00502
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q2KI94
UniProt Splice Variant
Entrez Gene 528912
UniGene Bt.57956
RefSeq NP_001039760
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC112721 DAAA02006379 DAAA02006380
GenPept AAI12722

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca